The exciting news just keeps coming: We’re thrilled to announce that
@DrDeanElterman
, urologist at University Urology Associates, in Toronto, Canada recently completed the world’s first commercial procedure of the Optilume BPH Catheter System!
#BPH
Exciting! The Canadian Journal of Urology has featured "How I Do It: Optilume BPH Catheter System" by
@DrDeanElterman
. Read about
#OptilumeBPH
's evolution, patient assessment, preparation, postoperative management and more at
#BPH
#Urology
@canjurol
Dr. Melanie Aube-Peterkin presenting
#Optilume
Urethral Drug Coated Balloon for the treatment of anterior
#UrethralStricture
4yr summary of ROBUST I, II, III. Sustained improvement in patient symptoms & flow rate with low reintervention rate vs. existing standard of care
We’re thrilled to announce that Dr. Alexis Te, Professor of Urology at
@WCMUrology
& Director of Urology at Iris Cantor Men's Health Center & Brady Urologic Health Center, completed the first U.S. commercial procedure of the
#Optilume
BPH Catheter System! Congratulations!
#BPH
At this aft's
#AUA23
plenary sessions,
@MaleHealthDoc
shared predictions of the future of
#BPH
, covering everything from the role
#AI
will play & new developments in diagnostics to what utilization of current and soon-to-be-available therapies look like, including Optilume BPH.
Proud to announce
#OptilumeDCB
has received US 🇺🇸 FDA approval for use in
#UrethralStrictures
THANK YOU to our Urotronic team, Physicians and patients for making this a reality and providing an alternative treatment option for millions of patients globally
Congratulations to Dr. Georgi Tosev (Mannheim, Germany) on performing the 1st
#Optilume
procedures in Europe. We are excited to collaborate with our strategic partner
@LABORIEMEDICAL
in Europe & we're committed to advancing patient care for the treatment of
#Urethral
#Stricture
Congrats
@DrDeanElterman
on performing the first Optilume BPH™ procedure in Canada. Now enrolling patients into the Pinnacle clinical trial. To learn about the study . Patients may learn about their eligibility to participate via
Interested to see a world first
@BAUSurology
? Good! Hear
@page_toby
discuss new innovations & devices in BPO to be introduced to
#OptilumeBPH
Early data is extremely positive with a 162 subject RCT ongoing in North America to follow
#MIST
#BAUS21
#BPH
Dr. Jill Hudson presents real-world New Brunswick 🇨🇦 experience data of
#Optilume
Urethral DCB
@CanUrolAssoc
#CUA2023
At 17.5 months F/U 87% free from reintervention in a cross section of real-world patient selection including prior radiated, penile, prior UP
#UrethralStricture
A busy
@BAUSurology
virtual congress for
#OptilumeDCB
21-23 June 2021. One presentation introducing
#OptilumeBPH
, a fascinating debate titled “Is Optilume the new dawn for endoscopic stricture management” and an ePoster session showcasing 3-year ROBUST I data!
#Exciting
Did you see? Optilume BPH is featured as one of
@AARP
's breakthroughs in men’s health for providing patients with lasting relief from their BPH symptoms. Check out the article here:
#BPH
#OptilumeBPH
#Urology
#EnlargedProstate
We’re delighted to announce
#OptilumeDCB
for the treatment of Urethral Stricture has received CE approval thus Urologist’s & patients now have access across Europe, inc. UK, to this groundbreaking technology
#Innovation
#UrethralStricture
We are proud to be one of those 32 companies (the only Medical Device Company) invited to present our innovation to all
@Arab_Health
as part of the
#Innov8
talks. Discussing
#Innovation
for the treatment of
#UrethralStricture
with the Optilume Drug Coated Balloon
Optilume is a novel procedure to treat BPH. We spoke with
@DrDeanElterman
about the new procedure. We discussed what makes the procedure unique, its risks and benefits, and how it stacks up against other BPH treatments:
👇👇👇
#BPH
#prostate
#optilume
We’re delighted to showcase early results of
#OptilumeDCB
#BPH
our
#Innovative
proprietary technology advancing
#MIS
treatments available without the need for cutting, lasering, vaporizing, stapling or steaming! We look forward to the long term efficacy results &
#PINNACLE
RCT
Thx
@UrologyTimes
for covering
@MaleHealthDoc
’s
#AUA23
presentation of 12-month data from the PINNACLE study that showed treatment with the Optilume BPH System resulted in significant, immediate symptomatic and functional improvements in patients with
#BPH
Delighted
@NICEComms
today published positive
#Optilume
Medtech Innovation Briefing
#MIB
for the treatment of urethral stricture. We look forward to adoption of this game changing technology benefiting the lives of
#UrethralStricture
patients
#innovation
Dr. Gerald Jordan &
@DavePerryUro
CEO of Urotronic discuss 1-Year clinical data of our innovative Optilume Drug Coated Balloon for the treatment of
#UrethralStricture
with many esteemed guests of the Urology Reconstruction world. Exciting developments
#Innovation
#EAU19
Featured on the front cover of The Journal of Urology: Optilume BPH's PINNACLE study results by
@MaleHealthDoc
demonstrate safe, effective relief of
#BPH
symptoms.
#Urology
@JUrology
Patient results & experience is critical. It's why innovative technologies such as
#OptilumeDCB
offer patients so much where existing treatments may not be ideal or suitable to their needs. Soon to market in EU
#UrethralStricture
#Innovation
via
@patient
Recognized for excellence & innovation, Urotronic’s
#Optilume
, now owned by
@LABORIEMEDICAL
, won the
@mntechassoc
2023 Tekne Award! We are honored to receive this recognition for Optilume’s groundbreaking solution & profound impact in treating men with
#BPH
& urethral strictures.
Thank you to Dr. Steven Kaplan (
@MaleHealthDoc
) for presenting sustained positive results from our two Optilume BPH clinical trials through 4 years today at
#AUA23
! If you missed it, learn more at: .
#BPH
#SoBPD
We look forward to welcoming all attending
#AUA19
. Want an effective, minimally invasive treatment with longer term relief for
#UrethralStricture
? Visit booth 4640 to hear more about
#Optilume
and how our innovative technology aims to shift the paradigm for patients & physicians!
Showcasing
#Optilume
@IMORU
11th-13th March in Hamburg with Gerald Jordan M.D. presenting 1-year Safety & Efficacy Outcomes of Optilume - ROBUST I Study. We look forward to introducing our innovative
#UrethralStricture
technology to all who are attending
We’re delighted to announce
#OptilumeDCB
for the treatment of Urethral Stricture has received CE approval thus Urologist’s & patients now have access across Europe, inc. UK, to this groundbreaking technology
#Innovation
#UrethralStricture
Welcome all to
#EAU19
We look forward to sharing our
#Innovation
for the treatment of
#UrethralStricture
with everybody attending. Visit booth J41 in Blue Area to hear further regarding
#Optilume
Drug Coated Balloon
We had an action-packed few days in Chicago at this year's
#AUA23
! Thx to everyone who stopped by our booth. For more information, including highlights from
@MaleHealthDoc
's podium presentations on the effectiveness and durability of Optilume BPH, visit .
We look forward to hosting Urologists and Urology Care Practicioners tomorrow evening (27th Oct) during our inaugural educational event launching our innovative solution
#Optilume
for the treatment of
#UrethralStricture
#Innovation
Showcasing
#Optilume
during the Patient Safety & Quality
#Innov8
talks
@Arab_Health
#InnovationHub
proudly finishing 2nd place runner up. A fantastic format providing awareness of game changing medical innovations that better patient outcomes to health authorities & HCP��s
Going to
#SMSNA
? Attend Dr. Osvaldo Padron’s session tmrw 11/18, 1.30 p.m.! He will be presenting important findings from the
#PINNACLE
RCT, including how effective
#Optilume
BPH is in preserving sexual function while treating
#BPH
symptoms. See you there!
Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial)
@beagoulao
@NDowJames
Great to see
@OptilumeBPH
being discussed and considered a future treatment option for
#BPH
Early clinical data is extremely promising. Nb.
#OptilumeBPH
is an investigational device in the United States. Limited by federal law to investigational use only
A whistle stop tour through BPH.
@RichardHindley1
- “So many new MISTs it’s a bit of a minefield”. Comprehensive overview of the many new technologies.
#BAUS23
@MaleHealthDoc
joined Grand Rounds in Urology to discuss the results of the
#PINNACLE
RCT. Listen for more information about the trial and what the positive results mean for the future of
#BPH
treatment.
As part of the Innovation Hub
@Arab_Health
2019, we are proud to be showcasing the Optilume DCB as a
#minimallyinvasive
#innovation
for treatment of Urethral Stricture. We are delighted to be 1 of only a handful of innovations chosen for
#Innov8
pitches
With additional long term clinical data collection in support of
#OptilumeDCB
ongoing, we are optimistic about the future of the technology in treating patients suffering
#UrethralStricture
@LaborieMedical
today completed the acquisition of Urotronic, Inc., bringing together the
#Optilume
Drug Coated Balloon product portfolio for
#UrethralStricture
&
#BPH
, and strengthening Laborie’s offering to physicians & patients in the field of
#Urology
Minimally invasive Optilume BPH Catheter System “can provide TURP-like results without cutting, burning, steaming, lasering, or leaving a permanent implant behind”—Dr. Steven A. Kaplan
#urology
#urologist
#BPH
Congratulations to our Italian distribution partner, ACTA Group, & their highly skilled team for assisting with the first
#Optilume
procedures in Italy at Policlinico di Monza with Dr. Tura. Italian men have an alternative option available for the treatment of
#UrethralStricture
For the future of minimally invasive
#BPH
treatment see WORLD EXCLUSIVE data abstract at
#WCET21
for
#OptilumeBPH
Interim 2yr Results for EVEREST-I Trial Evaluating the Optilume BPH Catheter System presented by
@Leedsurology
Available from Oct 23rd 2021 ?
We’re delighted to announce our strategic partnership with
@LABORIEMEDICAL
cementing our commitment to Urologist’s, Urology HCP’s and patients worldwide in offering truly innovative technologies that positive impact lives.
#OptilumeDCB
#UrethralStricture
Don't miss Dr. Steven Kaplan (
@MaleHealthDoc
) presenting positive data at
#AUA23
on Monday from 2 clinical trials evaluating effectiveness and durability of Optilume BPH. 4-year
#EVEREST
data at 7:20 a.m. and 12-month
#PINNACLE
data at 9:30 a.m.
#BPH